A large 2026 study found GLP-1 users lose more hair than people on other diabetes drugs, but the likely trigger is the weight loss itself, not the medication.
Yes, but it's probably not the drug itself doing the damage. A 2026 study of over 50,000 patients found GLP-1 users like those on Ozempic had a meaningfully higher rate of hair loss than people on other diabetes medications, and researchers think rapid weight loss, not semaglutide, is the real trigger.
What the new study actually found
Researchers at the University of Pennsylvania pulled electronic health records on adults with type 2 diabetes who started a new medication between 2019 and 2024. They compared people starting a GLP-1 drug, the class that includes Ozempic and Wegovy, against people starting a SGLT-2 inhibitor or a DPP-4 inhibitor, two other common diabetes drug families. After adjusting for other factors, GLP-1 starters had a 37% higher relative risk of being diagnosed with hair loss than the SGLT-2 group, and a 68% higher relative risk than the DPP-4 group, according to the study published in The BMJ. The hair loss was almost entirely non-scarring alopecia, the kind where follicles survive and hair can grow back. Yong Chen, the study's senior author and a professor of biostatistics at Penn's Perelman School of Medicine, put it plainly: "Hair loss has been reported anecdotally, but clinical trials to this point were not designed to evaluate this outcome." This is the largest look yet at a side effect that mostly lived in patient forums and social media comment sections until now.
Why weight loss itself is the more likely culprit
The study was observational, which means it can show that GLP-1 users lost more hair, not that the drug caused it directly. The researchers' own read is that rapid weight loss and the metabolic and nutritional shifts that come with it are doing most of the work. This lines up with decades of dermatology research on telogen effluvium, a stress-triggered shedding pattern that shows up two to four months after a sudden shock to the body: crash diets, major surgery, illness, extreme calorie deficits. Losing weight fast on a GLP-1 drug checks every one of those boxes. Mir Ali, a bariatric surgeon and medical director at MemorialCare Surgical Weight Loss Center who was not involved in the study, told Medical News Today that significant weight loss "by any means can result in hair loss," whether it comes from a drug, surgery, or dieting.
“Hair loss has been reported anecdotally, but clinical trials to this point were not designed to evaluate this outcome.”
How common this actually is
The relative risk numbers sound alarming, but the absolute numbers are small. Only a few patients out of every thousand on a GLP-1 drug were coded for hair loss in the study period. In Novo Nordisk's own Wegovy trials, about 3% of people on the highest dose reported hair thinning, against 1% on placebo, a real difference but hardly an epidemic. For most people starting these drugs, hair loss is not the thing to plan around. For a minority, especially people losing weight quickly or already running low on iron, protein, or B vitamins, it is a real and documented risk worth knowing about before it shows up unexplained in the shower drain.
What to do if your hair is thinning on the drug
Dermatologists generally treat drug or diet-related shedding the same way regardless of the trigger: check ferritin, B12, and vitamin D levels, make sure protein intake isn't crashing along with calories, and give it time, since telogen effluvium typically resolves within six to nine months once the trigger passes. What you should not do is stop a prescribed GLP-1 medication on your own. Dr Opel Baker, a GP at Mayfield Clinic in Brighton who reviewed the findings, said "the most important advice is not to panic and not to discontinue treatment without medical advice." If the shedding is heavy or doesn't slow down, that's a conversation for your prescriber, not a reason to quit cold.
“The most important advice is not to panic and not to discontinue treatment without medical advice.”
Does this apply to Wegovy and Mounjaro too
The Penn study looked at GLP-1 drugs as a class using real-world diabetes prescribing data, so it wasn't built to separate out Ozempic from Wegovy or tirzepatide-based drugs like Mounjaro. But the mechanism researchers point to, fast weight loss and nutritional strain, applies just as much to anyone losing significant weight quickly on any of these drugs, whatever the brand name. It's also consistent with the pattern already seen with other GLP-1 side effects like facial volume loss, where the drug's real effect is accelerating changes the body goes through with any rapid weight loss, not a chemical attack on one specific tissue.
Our take
The headline numbers here are real, but they describe a side effect of losing weight fast, not a unique danger of semaglutide or tirzepatide. If you're on one of these drugs and losing hair, it's a known, usually temporary, and manageable issue, not a reason to panic or stop treatment on your own. Get your bloodwork checked, keep protein up, and give it a few months before deciding anything is permanent.
This is general information, not medical advice. Talk to a clinician before changing anything, especially if you are pregnant, nursing, or managing a condition.
Frequently asked questions
Does Ozempic cause hair loss?
A 2026 BMJ study found GLP-1 users had a meaningfully higher rate of hair loss than people on other diabetes drugs, so there's a real statistical link. But researchers believe rapid weight loss, not semaglutide itself, is the likely cause, and the hair loss reported was non-scarring, meaning regrowth is possible.
Is Ozempic hair loss permanent?
Usually not. The pattern matches telogen effluvium, a stress-triggered shedding that follows sudden changes like rapid weight loss, and it typically resolves within six to nine months once the trigger passes, as long as the hair follicles themselves weren't damaged.
How common is hair loss on GLP-1 drugs?
The absolute numbers are small. Only a few patients per thousand were coded for hair loss in the 2026 BMJ study, and in Wegovy's own trials, about 3% of people on the highest dose reported thinning versus 1% on placebo, a real but modest difference.
Why does rapid weight loss cause hair loss?
Fast weight loss is a physical stressor that can push hair follicles into a resting phase early, called telogen effluvium. The same pattern shows up after crash diets, bariatric surgery, or sudden illness, which is why researchers suspect the weight loss itself, not the drug, is doing most of the work.
Can you prevent hair loss while on Ozempic?
There's no guaranteed prevention, but keeping protein intake up during rapid weight loss and checking ferritin, B12, and vitamin D levels can help. Losing weight more gradually, where your prescriber allows it, may also reduce the shedding stress on hair follicles.
Does Wegovy or Mounjaro also cause hair loss?
The 2026 study looked at GLP-1 drugs as a class, not individual brands, but the mechanism researchers point to, fast weight loss and nutritional strain, applies to anyone losing significant weight quickly on semaglutide or tirzepatide-based drugs, regardless of the brand name.
Sources
- 1
GLP-1 medications are linked to hair loss in people with type 2 diabetes, Managed Healthcare Executive
- 2
GLP-1 drugs linked to temporary hair loss, here's why, Medical News Today